US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET
|
Novartis International AG
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients1 The...
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO)
June 08, 2020 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
Ocutrx’s Oculenz Advances from AR Headset to Full Surgery Visualization Theatre
May 19, 2020 04:00 ET
|
Ocutrx Vision Technologies, LLC
KENSINGTON, London, May 19, 2020 (GLOBE NEWSWIRE) -- The maker of breakthrough augmented-extended reality (AR/XR) glasses that provide a radically new surgical viewing experience for retinal...
Graybug Vision Appoints Parisa Zamiri, Physician-Scientist with Deep Expertise in Ophthalmology, as Chief Medical Officer
May 18, 2020 07:30 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat vision-threatening...
OVITZ Gives Optometrists A Look into their Future with a New Level of Vision Improvement
May 14, 2020 09:36 ET
|
OVITZ
ROCHESTER, N.Y., May 14, 2020 (GLOBE NEWSWIRE) -- OVITZ, a company that develops innovative vision-enhancing technologies for contact lenses, announced today that its xwave system is now in beta use...
Ocutrx’s Oculenz Advances from AR Headset to Full Surgery Visualization Theatre
May 14, 2020 08:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- The maker of breakthrough augmented-extended reality (AR/XR) glasses that provide a radically new surgical viewing experience for retinal surgeons...
Clearside Biomedical Announces First Quarter 2020 Financial Results
May 08, 2020 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., May 08, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
ProQR Announces First Quarter 2020 Operating and Financial Results
May 07, 2020 07:00 ET
|
ProQR Therapeutics N.V.
Reported positive interim analysis findings from Phase 1/2 Stellar trial of QR-421a for Usher syndrome and non-syndromic retinitis pigmentosa – study ongoing with dose expansion and escalation...
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
April 28, 2020 07:05 ET
|
Clearside Biomedical, Inc.
- Management to Host Webcast and Conference Call Today at 8:30 A.M. ET - ALPHARETTA, Ga., April 28, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company...
Ocutrx Executive to Lead Augmented Reality Session in Global E-Conference on Ophthalmology
April 22, 2020 09:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, an advanced research and development manufacturer of Augmented Reality (AR) glasses, is pleased to announce that...